Search

everythinglearnresearchcommunity

for

Search:↓

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Nursing women in the West Bank with higher income and non-smoking habits have higher blood zinc levels.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.